Aastrom Biosciences Company Description
Aastrom Biosciences brings new life to dying tissue. Its Tissue Repair Cell (TRC) technology takes a small amount of bone marrow from a patient and uses it to grow stem and progenitor cells. The new cells, created through a sterile, automated process, are then used in tissue regeneration therapies for the donator patient. The company hopes the technology will treat various types of conditions, including degenerative vascular, bone, and central nervous system diseases. The TRC system is in clinical trials for bone, cardiovascular, and vascular regeneration.
View the Comprehensive Company Description for Aastrom Biosciences
The Company Description provides a historical perspective of Aastrom Biosciences's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Aastrom Biosciences's evolution in the marketplace.
